Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell G Kluesner

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|September 26, 2025
Installation of Dominant-Negative Mutations in <i>FAS</i> and <i>TGFβR2</i> via Base Editing in Primary T CellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
The CRISPR Journal|April 26, 2019
EditR: A Method to Quantify Base Editing from Sanger SequencingMitchell G Kluesner, Derek A Nedveck, Walker S Lahr, et al.
Molecular Therapy. Oncology|October 27, 2025
Installation of dominant-negative mutations in <i>FAS</i> and <i>TGFβR2</i> via base editing in primary T cellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
Molecular Therapy. Nucleic Acids|September 30, 2021
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seqMitchell G Kluesner, Rafail Nikolaos Tasakis, Taga Lerner, et al.
Plos One|September 18, 2018
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arraysMorito Kurata, Natalie K Wolf, Walker S Lahr, et al.
The CRISPR Journal|August 16, 2022
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing TechnologiesKelsie L Becklin, Garrett M Draper, Rebecca A Madden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapyJacob Bridge, Matthew J Johnson, Bibekananda Kar, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base EditingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|September 26, 2025
Installation of Dominant-Negative Mutations in <i>FAS</i> and <i>TGFβR2</i> via Base Editing in Primary T CellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
The CRISPR Journal|April 26, 2019
EditR: A Method to Quantify Base Editing from Sanger SequencingMitchell G Kluesner, Derek A Nedveck, Walker S Lahr, et al.
Molecular Therapy. Oncology|October 27, 2025
Installation of dominant-negative mutations in <i>FAS</i> and <i>TGFβR2</i> via base editing in primary T cellsBryce J Wick, Mitchell G Kluesner, Nicholas J Slipek, et al.
Molecular Therapy. Nucleic Acids|September 30, 2021
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seqMitchell G Kluesner, Rafail Nikolaos Tasakis, Taga Lerner, et al.
Plos One|September 18, 2018
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arraysMorito Kurata, Natalie K Wolf, Walker S Lahr, et al.
The CRISPR Journal|August 16, 2022
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing TechnologiesKelsie L Becklin, Garrett M Draper, Rebecca A Madden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapyJacob Bridge, Matthew J Johnson, Bibekananda Kar, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base EditingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Pageof 2